Pediatric Exclusivity Expansion Floated On Hill; Mandatory Study Bill Pending
Executive Summary
An additional three months of exclusivity would be awarded for a company's second round of pediatric studies under a proposed amendment to Sen. Hillary Rodham Clinton's (D-N.Y.) bill to codify FDA's mandatory pediatric study rule